- Home
- RAND vs GUTS Comparison
RAND vs GUTS Comparison
Compare RAND & GUTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAND
- GUTS
- Stock Information
- Founded
- RAND 1969
- GUTS 2010
- Country
- RAND United States
- GUTS United States
- Employees
- RAND N/A
- GUTS N/A
- Industry
- RAND Finance: Consumer Services
- GUTS
- Sector
- RAND Finance
- GUTS
- Exchange
- RAND Nasdaq
- GUTS NYSE
- Market Cap
- RAND 52.9M
- GUTS 54.8M
- IPO Year
- RAND N/A
- GUTS 2024
- Fundamental
- Price
- RAND $19.80
- GUTS $1.22
- Analyst Decision
- RAND
- GUTS Buy
- Analyst Count
- RAND 0
- GUTS 1
- Target Price
- RAND N/A
- GUTS $10.00
- AVG Volume (30 Days)
- RAND 9.1K
- GUTS 272.1K
- Earning Date
- RAND 05-12-2025
- GUTS 05-12-2025
- Dividend Yield
- RAND 24.79%
- GUTS N/A
- EPS Growth
- RAND 35.26
- GUTS N/A
- EPS
- RAND 3.42
- GUTS N/A
- Revenue
- RAND $8,559,285.00
- GUTS $93,000.00
- Revenue This Year
- RAND N/A
- GUTS N/A
- Revenue Next Year
- RAND N/A
- GUTS N/A
- P/E Ratio
- RAND $5.79
- GUTS N/A
- Revenue Growth
- RAND 16.64
- GUTS N/A
- 52 Week Low
- RAND $13.69
- GUTS $0.87
- 52 Week High
- RAND $31.89
- GUTS $7.89
- Technical
- Relative Strength Index (RSI)
- RAND 50.99
- GUTS 52.03
- Support Level
- RAND $17.07
- GUTS $0.87
- Resistance Level
- RAND $20.00
- GUTS $1.17
- Average True Range (ATR)
- RAND 1.27
- GUTS 0.11
- MACD
- RAND 0.29
- GUTS 0.02
- Stochastic Oscillator
- RAND 70.53
- GUTS 87.41
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.
About GUTS FRACTYL HEALTH INC
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.